Skip to Content

Metreleptin

In the US, Metreleptin (metreleptin systemic) is a member of the drug class miscellaneous metabolic agents and is used to treat Lipodystrophy.

US matches:

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0186018-45-1

Chemical Formula

C714-H1167-N191-O221-S6

Molecular Weight

16155

Therapeutic Category

Lipid lowering agent

Chemical Names

N-methionylleptin (human) (WHO)

VPIQKVQDDT KTLIKTIVTR INDISHTQSV SSKQKVTGLD FIPGLHPILT LSKMDQTLAV YQQILTSMPS RNVIQISNDL ENLRDLLHVL AFSKSCHLPW ASGLETLDSL GGVLEASGYS TEVVALSRLQ GSLQDMLWQL DLSPGC

Foreign Names

  • Metreleptinum (Latin)
  • Metreleptin (German)
  • Métréleptine (French)
  • Metreleptina (Spanish)

Generic Names

  • Metreleptin (OS: USAN, JAN)
  • UNII-TL60C27RLH (IS)
  • Metreleptin (PH: JP XV)

Brand Names

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide